Presence of filterable and nonfilterable mRNA in the plasma of cancer patients and healthy individuals.
BACKGROUND
As RNA is labile, we investigated whether circulating RNA in human plasma may be present in a particle-associated form.


METHODS
Blood was collected from 27 healthy individuals and 16 hepatocellular carcinoma (HCC) patients. The plasma from each individual was processed by two means: filtration through filters with different pore sizes (from 5 microm to 0.22 microm) and ultracentrifugation. We assessed plasma RNA content by a real-time quantitative reverse transcription-PCR assay for glyceraldehyde-3-phosphate dehydrogenase (GAPDH) transcripts and plasma DNA by a real-time quantitative PCR assay for the beta-globin gene.


RESULTS
The plasma GAPDH mRNA concentrations in the healthy individuals were significantly different in every pair of these filter sizes (P <0.05 for each pair). Overall, the plasma GAPDH mRNA concentration was higher by a median of 15-fold (interquartile range, 10- to 24-fold) in the paired unfiltered sample than in the sample filtered through a 0.22 microm filter. In contrast, no significant difference was seen in beta-globin DNA concentrations among different pore-size-filtered plasma samples (P = 0.455). Similarly, a significant difference was observed for RNA, but not DNA, between unfiltered plasma and ultracentrifuged plasma (P <0.05). No significant difference in GAPDH mRNA concentrations was seen between the 0.22-microm-filtered plasma samples and the ultracentrifuged plasma samples (P >0.05). In HCC patients, filtration with a 0.22 microm filter produced a median 9.3-fold (interquartile range, 6.9- to 311-fold) reduction in GAPDH mRNA concentration in plasma. Plasma GAPDH mRNA concentrations in HCC patients were significantly higher than those in healthy individuals, both with or without filtration (P <0.0 5 for filtered plasma samples; P <0.005 for unfiltered plasma samples).


CONCLUSIONS
A substantial proportion of plasma mRNA species is particle-associated. In HCC patients, both circulating particle- and non-particle-associated plasma RNA are increased.
Ng
Enders K O
EK
Institute of Molecular Oncology and Department of Chemical Pathology, The Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region.
Tsui
Nancy B Y
NB
Lam
Nicole Y L
NY
Chiu
Rossa W K
RW
Yu
Simon C H
SC
Wong
S C Cesar
SC
Lo
Elena S F
ES
Rainer
Timothy H
TH
Johnson
Philip J
PJ
Lo
Y M Dennis
YM
D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000175:diagnosis*; D005374:Filtration; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases / Q000097:blood* / Q000235:genetics; D006801:Humans; D008113:Liver Neoplasms / Q000097:blood / Q000175:diagnosis*; D010949:Plasma; D012333:RNA, Messenger / Q000097:blood*; D012016:Reference Values; D015203:Reproducibility of Results; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014461:Ultracentrifugation
D012333:RNA, Messenger; D005987:Glyceraldehyde-3-Phosphate Dehydrogenases